Interleukin-15 stimulates macrophages to activate CD4+ T cells: A role in the pathogenesis of rheumatoid arthritis?

Immunology

Volumn 126, Issue 1, 2009, Pages 63-73

  Rückert, René ^a,d   Brandt, Katja ^a,e   Ernst, Martin ^a   Marienfeld, Kathleen ^a   Csernok, Elena ^b   Metzler, Claudia ^b   Budagian, Vadim ^a   Bulanova, Elena ^a   Paus, Ralf ^c   Bulfone Paus, Silvia ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d BAYER PHARMA AG   (Germany)

^e POTSDAM INSTITUTE FOR CLIMATE IMPACT RESEARCH PIK   (Germany)

Author keywords

Cytokines; Macrophages; Rheumatoid arthritis; T cells

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INTERLEUKIN 15; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL INTERACTION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; FEMALE; HUMAN; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

AGED; ANIMALS; ANTIGEN PRESENTATION; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-15; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; PHAGOCYTOSIS; RECEPTORS, INTERLEUKIN-15; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 57449116787     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02878.x     Document Type: Article

References (38)

1. Giron-Michel J, Caignard A, Fogli M et al. Differential STAT3, STAT5, and NF-kappaB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules. Blood 2003 102 : 109 17.
2. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001 97 : 14 32.
3. Bulfone-Paus S, Bulanova E, Budagian V, Paus R. The interleukin-15/ interleukin-15 receptor system as a model for juxtacrine and reverse signaling. Bioessays 2006 28 : 362 77.
4. Rückert R, Brandt K, Bulanova E, Mirghomizadeh F, Paus R, Bulfone-Paus S. Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur J Immunol 2003 33 : 3493 03.
5. Waldmann T. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases. Arthritis Res 2002 4 (Suppl. 3 S161 7.
6. Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. J Immunol 1996 156 : 735 41.
7. Alleva DG, Kaser SB, Monroy MA, Fenton MJ, Beller DI. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol 1997 159 : 2941 51.
8. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 1997 3 : 189 95.
9. McInnes IB, Gracie JA, Harnett M, Harnett W, Liew FY. New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis 2003 62 (Suppl. 2 ii51 4.
10. Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 1998 160 : 5654 60.
11. - T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004 109 : 2744 8.
12. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996 97 : 2027 37.
13. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 31 : 315 24.
14. van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998 41 : 1845 50.
15. Stumbles PA, Thomas JA, Pimm CL, Lee PT, Venaille TJ, Proksch S, Holt PG. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998 188 : 2019 31.
16. Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis 2002 61 (Suppl. 2 ii84 6.
17. Kondo M, Scherer DC, Miyamoto T, King AG, Akashi K, Sugamura K, Weissman IL. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 2000 407 : 383 6.
18. Brandt K, Bulfone-Paus S, Foster DC, Rückert R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 2003 102 : 4090 8.
19. Klausen P, Bjerregaard MD, Borregaard N, Cowland JB. End-stage differentiation of neutrophil granulocytes in vivo is accompanied by up-regulation of p27kip1 and down-regulation of CDK2, CDK4, and CDK6. J Leukoc Biol 2004 75 : 569 78.
20. Xaus J, Cardo M, Valledor AF, Soler C, Lloberas J, Celada A. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 1999 11 : 103 13.
21. Kubo M, Hanada T, Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol 2003 4 : 1169 76.
22. Ojaniemi M, Glumoff V, Harju K, Liljeroos M, Vuori K, Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol 2003 33 : 597 605.
23. Rückert R, Herz U, Paus R, Ungureanu D, Pohl T, Renz H, Bulfone-Paus S. IL-15-IgG2b fusion protein accelerates and enhances a Th2 but not a Th1 immune response in vivo, while IL-2-IgG2b fusion protein inhibits both. Eur J Immunol 1998 28 : 3312 20.
24. Agostini C, Zambello R, Facco M et al. CD8 T-cell infiltration in extravascular tissues of patients with human immunodeficiency virus infection. Interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction. Blood 1999 93 : 1277 86.
25. Miranda-Carus ME, Balsa A, Benito-Miguel M, Perez dA, Martin-Mola E. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J Immunol 2004 173 : 1463 76.
26. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 2002 17 : 537 47.
27. Kennedy MK, Glaccum M, Brown SN et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000 191 : 771 80.
28. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998 9 : 669 76.
29. + T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12/IL-4 stimulation in vitro. Eur J Immunol 2002 32 : 341 7.
30. Nakayama K, Ishida N, Shirane M et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996 85 : 707 20.
31. Nourse J, Firpo E, Flanagan WM et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994 372 : 570 3.
32. Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Rückert R, Krause H, Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 1997 3 : 1124 8.
33. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el Houseini ME. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994 9 : 3389 96.
34. Andersson A, Grunewald SM, Duschl A, Fischer A, DiSanto JP. Mouse macrophage development in the absence of the common gamma chain: defining receptor complexes responsible for IL-4 and IL-13 signaling. Eur J Immunol 1997 27 : 1762 8.
35. Reya T, Contractor NV, Couzens MS, Wasik MA, Emerson SG, Carding SR. Abnormal myelocytic cell development in interleukin-2 (IL-2) -deficient mice: evidence for the involvement of IL-2 in myelopoiesis. Blood 1998 91 : 2935 47.
36. Lohmann-Matthes ML, Emmendoerffer A, Hao L. Influence of interleukin-2 on the differentiation of macrophages. Pathobiology 1991 59 : 117 21.
37. Liew FY, McInnes IB. Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 2002 61 (Suppl. 2 ii 100 2.
38. Miranda-Carus ME, Benito-Miguel M, Balsa A, Cobo-Ibanez T, Perez de Ayala C, Pascual-Salcedo D, Martin-Mola E. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum 2006 54 : 1151 64.